Sean Carroll

Sean Michael Carroll is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Director of Portfolio & Business Development at Manifold Bio since April 2023, where responsibilities include translating an innovative drug discovery platform into therapeutic programs and partnerships. Previously, as Associate Director of Portfolio Development at Corbus Pharmaceuticals, Sean led search and evaluation activities to build an oncology-focused therapeutic portfolio. Sean's extensive experience also encompasses significant roles at Axcella, where contributions included corporate development and driving R&D innovation, as well as positions with KnipBio, Harvard University, and the University of Oregon, focusing on microbial strain development, synthetic biology, and molecular evolution, respectively. Sean holds a Ph.D. in Molecular Biology & Evolution from the University of Oregon and a B.A. in Biology from McDaniel College.